Targeting SREBP-1-driven Lipid Metabolism to Treat Cancer
2014 · Current Pharmaceutical Design · 307 citations
https://doi.org/10.2174/13816128113199990486
E
Erica H. Bell
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
184
Papers
3.2K
Citations
22
h-index
26
i10-index
Erica H. Bell is an academic researcher from The Ohio State University. The author has contributed to research in topics: Chromatin Remodeling and Cancer & Glioma Diagnosis and Treatment & Mechanisms of cancer metastasis. The author has an h-index of 22, co-authored 157 publications.
ORCID: 0000-0001-7488-4695Papers by this author
worksGlioblastoma pseudoprogression and true progression reveal spatially variable transcriptional differences
2023 · Acta Neuropathologica Communications · 11 citations
https://doi.org/10.1186/s40478-023-01587-w
TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathways
2023 · Scientific Reports · 8 citations
https://doi.org/10.1038/s41598-023-32983-w
GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tau
2025 · Nature Communications · 4 citations
https://doi.org/10.1038/s41467-025-58585-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat